secwatch.observer — SEC 8-K summary
======================================

Issuer:     Krystal Biotech, Inc. (KRYS)
CIK:        0001711279
Form:       8-K
Filed at:   2024-05-21T23:59:59+00:00
Accession:  0001711279-24-000027
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Krystal Biotech stockholders elect directors, ratify auditor, approve say-on-pay at 2024 annual meeting
--------------------------------------------------------------------------------

- Class I directors Suma M. Krishnan, Julian S. Gangolli, and Catherine Mazzacco elected with 21.1M, 17.2M, and 20.4M votes for, respectively.
- Ratification of KPMG as independent auditor for FY2024: 24.8M for, 7.4K against, 22.8K abstentions.
- Advisory approval of named executive officer compensation for FY2023: 21.7M for, 851.7K against, 7.0K abstentions.
- Broker non-votes of 2.2M for director election and say-on-pay; no broker non-votes on auditor ratification.
- All proposals passed with strong majority support; no material changes to board or governance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711279/000171127924000027/0001711279-24-000027-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711279/000171127924000027/krys-20240521.htm
  HTML page:      https://secwatch.observer/filing/0001711279-24-000027

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer